New Wave Ventures

Poolside is an artificial intelligence platform that offers foundation concepts and infrastructure. It aims to unlock humanity's potential by pursuing AGI for software creation, with the fundamental belief that the transitional path for humanity to AGI is by building specific capabilities instead of a general-purpose approach. It also helps users utilize the power of software creation and understand future systems.

Regenerys Ltd. specializes in developing and selling regenerative medicine products focused on bioprocessing and biostorage. The company offers several innovative products, including Myskin, which uses cultured cells from a patient's own skin for treating serious burns and hard-to-heal wounds, and Cryoskin, which employs autologous cells for burn treatment. Additionally, Regenerys provides Adiposet, a service that enhances cosmetic outcomes in breast cancer surgeries and other aesthetic procedures by enabling the storage and return of adipose tissue. The company also delivers third-party bioprocessing and biostorage services through its laboratories. Serving both NHS and private healthcare providers, Regenerys operates primarily in the United Kingdom and Europe. Established in 2011, the company is headquartered in Cambridge, United Kingdom.

Xerion Healthcare Limited, founded in 2015 and based in Thame, United Kingdom, specializes in developing and commercializing innovative nanoparticle treatments aimed at improving cancer care. The company focuses on utilizing titanium dioxide nanoparticles, which are injected into tumors prior to standard radiotherapy. This method enhances the effectiveness of radiotherapy by amplifying the dose of free radicals generated by X-rays, allowing for more effective treatment of dense tumors. Xerion Healthcare is currently advancing its technology for head, neck, and pancreatic cancers, with the goal of improving patient outcomes while minimizing side effects associated with conventional cancer treatments.

Spectromics Limited is a diagnostic technology company based in Manchester, United Kingdom, founded in 2014. The company specializes in developing a point-of-prescription test designed to guide antibiotic treatment for bacterial infections. This innovative system detects bacterial susceptibility to drugs by analyzing the underlying metabolism of pathogens. By identifying antimicrobial susceptibility and resistance during patient appointments, Spectromics aims to assist healthcare professionals in eliminating ineffective empirical prescriptions, thereby providing targeted treatment recommendations for specific pathogens. This approach enhances the effectiveness of antibiotic treatment and contributes to improved patient outcomes.

Surface Generation Ltd. is a high technology and manufacturing company based in Oakham, United Kingdom, with additional facilities in North America and Asia. Founded in 2002, the company specializes in developing and commercializing composite processing equipment for the aerospace, automotive, and consumer electronics industries. Its patented Production to Functional Specification (PtFS) technology optimizes the use of composite materials, such as carbon fiber, enabling clients to produce high-performance products like aircraft wings, automotive components, and consumer devices. Surface Generation also provides manufacturing solutions for creating coupons, sub-element components, and demonstrator articles, as well as custom equipment for various applications, including oil and gas and academic research. The company's innovations help manufacturers save costs and energy while producing lighter weight products.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

Nanna Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on developing drugs for age-related diseases, including mitochondrial, neurodegenerative, cardiovascular/metabolic, joint/tissue diseases, and cancer. Founded in 2012, the company aims to address the unmet medical needs in these areas by targeting fundamental cellular processes to create innovative treatments. Nanna Therapeutics employs a proprietary platform known as the Totally Integrated Medicines Engine (TIME), which utilizes advanced technologies such as microfluidics, nanofabrication, and artificial intelligence to enhance drug discovery. This platform enables the rapid creation and functional screening of millions of novel compounds, thereby accelerating the development of transformative medicines for conditions that currently lack effective therapies. As of April 2020, Nanna Therapeutics operates as a subsidiary of Astellas Pharma Europe Ltd.

Endomag is a medical technology company focused on enhancing cancer care standards globally. Founded in 2007 as a spin-out from the University of Houston and University College London, the company has developed advanced magnetic sensing technology that aids in minimally invasive surgical guidance. Its key products, including the Sentimag probe, Magseed marker, and Magtrac node marker, are utilized by leading physicians and cancer centers worldwide. Endomag's mission is to help women with breast cancer avoid unnecessary surgeries and achieve better outcomes when surgery is required. Since its inception, the company has assisted over 70,000 women in accessing more precise and less invasive breast cancer care. Headquartered in Cambridge, United Kingdom, Endomag distributes its products across Europe, the Middle East, Africa, and Australasia.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

SPARKL Limited, founded in 2012 and based in London, United Kingdom, specializes in transaction router solutions that enhance business-level transactions through service level agreements. The company's primary product, the SPARKL Sequencing Engine, allows users to manage the behavior of distributed machines, systems, and applications. Utilizing a straightforward, declarative configuration known as Clear Box, the engine facilitates intelligent integration among various components while generating a tamper-proof audit trail to ensure regulatory compliance and optimize system performance. SPARKL collaborates with notable partners such as Cisco and Intel to expand its market reach and deliver its innovative solutions to a global audience.

Endomag is a medical technology company focused on enhancing cancer care standards globally. Founded in 2007 as a spin-out from the University of Houston and University College London, the company has developed advanced magnetic sensing technology that aids in minimally invasive surgical guidance. Its key products, including the Sentimag probe, Magseed marker, and Magtrac node marker, are utilized by leading physicians and cancer centers worldwide. Endomag's mission is to help women with breast cancer avoid unnecessary surgeries and achieve better outcomes when surgery is required. Since its inception, the company has assisted over 70,000 women in accessing more precise and less invasive breast cancer care. Headquartered in Cambridge, United Kingdom, Endomag distributes its products across Europe, the Middle East, Africa, and Australasia.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

Tapit is a leader in the contactless communications industry, specializing in near-field communications (NFC) technology since its inception in 2011. The company collaborates with major global brands to deploy, manage, and analyze contactless infrastructure, including NFC tags, beacons, and QR codes. By utilizing Tapit's technology, businesses can engage consumers directly through their smartphones in physical environments such as retail locations and outdoor media. This innovative approach simplifies content management by allowing users to create, deliver, manage, and report information in real-time, significantly reducing the need for manual input methods like searching or typing. Through its solutions, Tapit enhances consumer interaction and streamlines communication for its clients.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

Surrey NanoSystems Limited is a manufacturer of nanoscale materials, specializing in advanced super-black coatings, notably Vantablack. This innovative coating is applied to surfaces using vacuum-deposition technology, as well as through spraying and post-processing methods. Vantablack is utilized in a diverse array of applications, including stray light suppression, architectural lighting, sensors, telescopes, infrared imaging systems, and cinematography optics. Additionally, the coating enhances the performance of sensitive electro-optical imaging systems, making it valuable in sectors such as aerospace, automotive safety, architecture, and luxury goods. Founded in 2006 and headquartered in Newhaven, United Kingdom, Surrey NanoSystems was previously known as CEVP Limited before adopting its current name in December 2006.

Netmania Solutions, operating as Enhanced Telecommunications Ltd, specializes in device management solutions and has been active in the TR-069 delivery and deployment sector since 2001. The company provides both software and hardware services tailored for a variety of industries, including Internet service providers, cable operators, education, health, and enterprises of all sizes. Its offerings encompass software development services such as product development, data migration, and online systems, all aimed at enhancing customer experiences, reducing churn, and improving profitability for its clients.

Endomag is a medical technology company focused on enhancing cancer care standards globally. Founded in 2007 as a spin-out from the University of Houston and University College London, the company has developed advanced magnetic sensing technology that aids in minimally invasive surgical guidance. Its key products, including the Sentimag probe, Magseed marker, and Magtrac node marker, are utilized by leading physicians and cancer centers worldwide. Endomag's mission is to help women with breast cancer avoid unnecessary surgeries and achieve better outcomes when surgery is required. Since its inception, the company has assisted over 70,000 women in accessing more precise and less invasive breast cancer care. Headquartered in Cambridge, United Kingdom, Endomag distributes its products across Europe, the Middle East, Africa, and Australasia.

Orthogem Limited specializes in developing and manufacturing synthetic bone grafts, utilizing its patented Tripore technology platform. This innovative platform has led to a diverse range of synthetic bone grafts (SBGs) designed for various clinical applications, including spinal and oral craniofacial surgeries. Orthogem's product offerings include TriPore Granules, TriPore MPA, and TriPore Blocks. Established in 2001 and headquartered in Nottingham, United Kingdom, the company focuses on achieving optimal bone remodeling through the osteoconductive and bioactive properties of its materials. These grafts are applicable for treating a wide array of conditions, including fractures, congenital disorders, traumatic injuries, and bone cancer, thereby providing reliable solutions for patients undergoing procedures such as lumbar spine fusion.

Aeristech Limited, founded in 2006 and based in Kenilworth, United Kingdom, specializes in developing electric air compressors for the automotive industry. The company manufactures a range of products, including electric superchargers and full electric turbochargers, which enhance engine efficiency and support engine downsizing. Aeristech also produces fuel cell air compressors designed to maintain consistent air pressure despite fluctuations in airflow or input voltage. In addition to its automotive focus, the firm serves industrial applications by providing components such as motor accelerators and hydrogen fuel compressors, which facilitate effective fuel combustion at low rates. The company operates as an engineering research and development consultancy, aiming to innovate in hybrid turbo technology and support advancements in battery electric vehicle cooling systems.